Back to REGN
TRUIST FINANCIAL CORP REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
15
Latest value
$8.2M
Q3 2026
Peak value
$26M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $13.5M |
| Q3 2025 | $21K |
| Q3 2025 | $8.1M |
| Q4 2025 | $10.7M |
| Q4 2025 | $18.9M |
| Q4 2025 | $58K |
| Q1 2026 | $21M |
| Q1 2026 | $56K |
| Q1 2026 | $10M |
| Q2 2026 | $16.9M |
| Q2 2026 | $44K |
| Q2 2026 | $7.2M |
| Q3 2026 | $26M |
| Q3 2026 | $53K |
| Q3 2026 | $8.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $8.2M | 10.8K | — | — |
| Q3 2026 | $53K | 70 | — | — |
| Q3 2026 | $26M | 34.3K | — | — |
| Q2 2026 | $7.2M | 11.5K | — | — |
| Q2 2026 | $44K | 70 | — | — |
| Q2 2026 | $16.9M | 27.2K | — | — |
| Q1 2026 | $10M | 12.9K | — | — |
| Q1 2026 | $56K | 72 | — | — |
| Q1 2026 | $21M | 27.1K | — | — |
| Q4 2025 | $58K | 75 | — | — |
| Q4 2025 | $18.9M | 24.5K | — | — |
| Q4 2025 | $10.7M | 13.9K | — | — |
| Q3 2025 | $8.1M | 14.4K | — | — |
| Q3 2025 | $21K | 38 | — | — |
| Q3 2025 | $13.5M | 24.0K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B